Cargando…
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands
For a variety of cancer types, platinum compounds are still among the best treatment options. However, their application is limited by side effects and drug resistance. Consequently, multi-targeted platinum(IV) prodrugs that target specific traits of the malignant tissue are interesting new candidat...
Autores principales: | Mendrina, Theresa, Poetsch, Isabella, Schueffl, Hemma, Baier, Dina, Pirker, Christine, Ries, Alexander, Keppler, Bernhard K., Kowol, Christian R., Gibson, Dan, Grusch, Michael, Berger, Walter, Heffeter, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967619/ https://www.ncbi.nlm.nih.gov/pubmed/36839999 http://dx.doi.org/10.3390/pharmaceutics15020677 |
Ejemplares similares
-
Structure–Activity
Relationships of Triple-Action
Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating
Ligands
por: Fronik, Philipp, et al.
Publicado: (2021) -
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023) -
Improving the Stability of EGFR Inhibitor Cobalt(III)
Prodrugs
por: Mathuber, Marlene, et al.
Publicado: (2020) -
A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt(IV) Complexes under Physiological Conditions
por: Kastner, Alexander, et al.
Publicado: (2019) -
Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
por: Raveendran, Raji, et al.
Publicado: (2016)